Delivery of hydrophilic drugs
AssigneeUniversity College London
InventorsIjeoma Uchegbu, Aikaterini Lalatsa, Andreas Schatzlein
Life of this patent
Estimating the term…
Abstract
Compositions comprising a lipophilic derivative of a hydrophilic drug and an amphiphile compound for use in therapy of the human or animal body are provided. Methods of medical treatment, wherein a composition according to the invention is administered to a human or animal body also form part of the invention. It is preferred that the drug is delivered to the brain.
Claims7
A composition comprising a lipophilic derivative of the hydrophilic neuropeptide Leucine[5]-Enkephalin and an amphiphile compound,
- wherein the derivative comprises a lipophilic linker attached to the side chain oxygen of the tyrosine in the Leucine[5]-Enkephalin, wherein the linker is of the formula —C(C═O)R1, wherein R1 is C4-20 alkyl;
- wherein the amphiphile compound is quaternary palmitoyl glycol chitosan (GCPQ);
- and
- wherein the composition is formulated for human or animal administration by all routes except for the topical route.
A pharmaceutical composition comprising a lipophilic derivative of the hydrophilic neuropeptide Leucine[5]-Enkephalin, an amphiphile compound and one or more pharmaceutically acceptable excipients,
- wherein the derivative comprises a lipophilic linker attached to the side chain oxygen of the tyrosine in the Leucine[5]-Enkephalin, wherein the linker is of the formula —C(C═O)R1, wherein R1 is C4-20 alkyl;
- wherein the amphiphile compound is quaternary palmitoyl glycol chitosan (GCPQ);
- and
- wherein the composition is formulated for human or animal administration by all routes except for the topical route.
Dependencies are inferred from the claim text.